论文部分内容阅读
异基因造血干细胞移植是治疗恶性血液病最有效方法之一,特别是具有高危因素患者,异基因造血干细胞移植尤其为首选治疗。近年来随着免疫学的进展,单克隆抗体(以下简称单抗)在自体造血干细胞移植(AHSCT)体内外净化研究中得到广泛应用。单抗因具有高度特异性大大改善了净化的效果,
Allogeneic hematopoietic stem cell transplantation is one of the most effective methods for the treatment of hematologic malignancies. Especially in patients with high risk factors, allogeneic hematopoietic stem cell transplantation is especially the preferred treatment. In recent years, with the progress of immunology, monoclonal antibodies (hereinafter referred to as monoclonal antibodies) are widely used in in vitro and in vivo purification of autologous hematopoietic stem cell transplantation (AHSCT). Due to the high specificity of the monoclonal antibody has greatly improved the effect of purification,